Early exposure to probiotics in a canine model of atopic dermatitis has long-term clinical and immunological effects

Veterinary Immunology and Immunopathology

Volumn 146, Issue 2, 2012, Pages 185-189

  Marsella, Rosanna ^a   Santoro, Domenico ^b   Ahrens, Kim ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Atopic dermatitis; Dogs; Lactobacillus rhamnosus GG; Probiotics

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 10; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; EXPERIMENTAL DOG; FEMALE; FOLLOW UP; LACTOBACILLUS RHAMNOSUS; MALE; NONHUMAN; PHLEUM PRATENSE; RAGWEED;

ANIMALS; DERMATITIS, ATOPIC; DERMATOPHAGOIDES FARINAE; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; IMMUNOGLOBULIN E; INTERLEUKIN-10; LACTOBACILLUS RHAMNOSUS; PROBIOTICS; TRANSFORMING GROWTH FACTOR BETA;

AMBROSIA; CANIS FAMILIARIS; DERMATOPHAGOIDES FARINAE; LACTOBACILLUS RHAMNOSUS; PHLEUM PRATENSE;

EID: 84859497831     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.02.013     Document Type: Article

References (38)

1. Akbari O., DeKruyff R.H., Umetsu D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2001, 2:725-731.
2. Betsi G.I., Papadavid E., Falagas M.E. Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am. J. Clin. Dermatol. 2008, 9:93-103.
3. Boyle R.J., Ismail I.H., Kivivuori S., Licciardi P.V., Robins-Browne R.M., Mah L.J., Axelrad C., Moore S., Donath S., Carlin J.B., Lahtinen S.J., Tang M.L. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy 2011, 66:509-516.
4. de Roock S., van Elk M., van Dijk M.E., Timmerman H.M., Rijkers G.T., Prakken B.J., Hoekstra M.O., de Kleer I.M. Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin. Exp. Allergy 2010, 40:103-110.
5. Elmadfa I., Klein P., Meyer A.L. Immune-stimulating effects of lactic acid bacteria in vivo and in vitro. Proc. Nutr. Soc. 2010, 69:416-420.
6. Gerasimov S.V., Vasjuta V.V., Myhovych O.O., Bondarchuk L.I. Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial. Am. J. Clin. Dermatol. 2010, 11:351-361.
7. Griffin C.E., DeBoer D.J. The ACVD task force on canine atopic dermatitis (XIV): clinical manifestations of canine atopic dermatitis. Vet. Immunol. Immunopathol. 2001, 81:255-269.
8. Grize L., Gassner M., Wüthrich B., Bringolf-Isler B., Takken-Sahli K., Sennhauser F.H., Stricker T., Eigenmann P.A., Braun-Fahrländer C. Swiss Surveillance Programme on Childhood Allergy and Respiratory symptoms with respect to Air Pollution (SCARPOL) team. Trends in prevalence of asthma, allergic rhinitis and atopic dermatitis in 5-7-year old Swiss children from 1992 to 2001. Allergy 2006, 61:556-562.
9. Kalliomäki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001, 357:1076-1079.
10. Kalliomäki M., Salminen S., Poussa T., Arvilommi H., Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Res. Lett. (Lancet) 2003, 361:1869-1871.
11. Kalliomäki M., Antoine J.M., Herz U., Rijkers G.T., Wells J.M., Mercenier A. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J. Nutr. 2010, 140:713S-721S.
12. Isolauri E., Arvola T., Suetas Y., Moilanene E., Salminen S. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 2000, 30:1604-1610.
13. Liu A.H. Hygiene theory and allergy and asthma prevention. Paediatr. Perinat. Epidemiol. 2007, 21(Suppl. 3):2-7.
14. Looringh van Beeck F.A., Hoekstra H., Brunekreef B., Willemse T. Inverse association between endotoxin exposure and canine atopic dermatitis. Vet. J. 2011, 190:215-219.
15. López P., Gueimonde M., Margolles A., Suárez A. Distinct Bifidobacterium strains drive different immune responses in vitro. Int. J. Food Microbiol. 2010, 138:157-165.
16. Majkowska-Wojciechowska B., Pełka J., Korzon L., Kozłowska A., Kaczała M., Jarzebska M., Gwardys T., Kowalski M.L. Prevalence of allergy, patterns of allergic sensitization and allergy risk factors in rural and urban children. Allergy 2007, 62:1044-1050.
17. Marsella R., Olivry T. Animal models of atopic dermatitis. Clin. Dermatol. 2003, 21:122-133.
18. Marsella R., Olivry T., Nicklin C., Lopez J. Pilot investigations toward a model for canine atopic dermatitis: environmental challenges with house dust mites in high IgE producing Beagles, in mite hypersensitive dogs with natural occurring atopic dermatitis and in normal dogs. Vet. Dermatol. 2006, 17:24-35.
19. Marsella R., Girolomoni G. Canine models of atopic dermatitis: a useful tool with untapped potential. J. Invest. Dermatol. 2009, 129:2351-2357.
20. Marsella R. Evaluation of Lactobacillus rhamnosus strain GG for the prevention of atopic dermatitis in dogs. Am. J. Vet. Res. 2009, 70:735-740.
21. Matricardi P.M. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: controversial aspects of the 'hygiene hypothesis'. Clin. Exp. Immunol. 2010, 160:98-105.
22. Meyer A.L., Elmadfa I., Herbacek I., Micksche M. Probiotic, as well as conventional yogurt, can enhance the stimulated production of proinflammatory cytokines. J. Hum. Nutr. Diet 2007, 20:590-598.
23. Meury S., Molitor V., Doherr M.G., Roosje P., Leeb T., Hobi S., Wilhelm S., Favrot C. Role of the environment in the development of canine atopic dermatitis in Labrador and golden retrievers. Vet. Dermatol. 2011, 22:327-334.
24. Niers L.E., Timmerman H.M., Rijkers G.T., van Bleek G.M., van Uden N.O., Knol E.F., Kapsenberg M.L., Kimpen J.L., Hoekstra M.O. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin. Exp. Allergy 2005, 35:1481-1489.
25. Nødtvedt A., Egenvall A., Bergvall K., Hedhammar A. Incidence of and risk factors for atopic dermatitis in a Swedish population of insured dogs. Vet. Rec. 2006, 159:241-246.
26. Ohashi Y., Ushida K. Health-beneficial effects of probiotics: its mode of action. Anim. Sci. J. 2009, 80:361-371.
27. Olivry T., Marsella R., Iwasaki T., Mueller R. International task force on canine atopic dermatitis. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Vet. Dermatol. 2007, 18:78-86.
28. Ozdemir O. Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data. Clin. Exp. Immunol. 2010, 160:295-304.
29. Parronchi P., Brugnolo F., Sampognaro S., Maggi E. Genetic and environmental factors contributing to the onset of allergic disorders. Int. Arch. Allergy Immunol. 2000, 121:2-9.
30. Rijkers G.T., Bengmark S., Enck P., Haller D., Herz U., Kalliomaki M., Kudo S., Lenoir-Wijnkoop I., Mercenier A., Myllyluoma E., Rabot S., Rafter J., Szajewska H., Watzl B., Wells J., Wolvers D., Antoine J.M. Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J. Nutr. 2010, 140:671S-676S.
31. Rose M.A., Stieglitz F., Köksal A., Schubert R., Schulze J., Zielen S. Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at risk. Clin. Exp. Allergy 2010, 40:1398-1405.
32. Schäfer T., Merkl J., Klemm E., Wichmann H.E., Ring J. We and our pets: allergic together?. Acta Vet. Hung. 2008, 56:153-161.
33. Strasser A., Kalmar E., Niedermüller H. A simple method for the simultaneous separation of peripheral blood mononuclear and polymorphonuclear cells in the dog. Vet. Immunol. Immunopathol. 1998, 62:29-35.
34. Tang M.L., Lahtinen S.J., Boyle R.J. Probiotics and prebiotics: clinical effects in allergic disease. Curr. Opin. Pediatr. 2010, 22:626-634.
35. van Hoffen E., Korthagen N.M., de Kivit S., Schouten B., Bardoel B., Duivelshof A., Knol J., Garssen J., Willemsen L.E. Exposure of intestinal epithelial cells to UV-killed Lactobacillus GG but not Bifidobacterium breve enhances the effector immune response in vitro. Int. Arch. Allergy Immunol. 2010, 152:159-168.
36. von der Weid T., Bulliard C., Schiffrin E.J. Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin. Diagn. Lab. Immunol. 2001, 8:695-701.
37. Weese J.S., Anderson M.E. Preliminary evaluation of Lactobacillus rhamnosus strain GG (LGG), a potential probiotic in dogs. Can. Vet. J. 2002, 43:771-774.
38. Yura A., Kouda K., Iki M., Shimizu T. Trends of allergic symptoms in school children: large-scale long-term consecutive cross-sectional studies in Osaka Prefecture. Jpn. Pediatr. Allergy Immunol. 2011, 22:631-637.